AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 49 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $655,714 | -7.3% | 428,571 | 0.0% | 0.10% | -73.2% |
Q2 2023 | $707,142 | +44.7% | 428,571 | 0.0% | 0.39% | +198.5% |
Q1 2023 | $488,571 | +26.4% | 428,571 | 0.0% | 0.13% | +261.1% |
Q4 2022 | $386,614 | -22.8% | 428,571 | 0.0% | 0.04% | -59.1% |
Q3 2022 | $501,000 | +82.8% | 428,571 | 0.0% | 0.09% | +104.7% |
Q2 2022 | $274,000 | -75.5% | 428,571 | 0.0% | 0.04% | -48.2% |
Q1 2022 | $1,119,000 | -32.9% | 428,571 | 0.0% | 0.08% | -18.6% |
Q4 2021 | $1,667,000 | -10.8% | 428,571 | 0.0% | 0.10% | -38.2% |
Q3 2021 | $1,869,000 | +9.9% | 428,571 | 0.0% | 0.16% | +10.7% |
Q2 2021 | $1,701,000 | -23.7% | 428,571 | 0.0% | 0.15% | -22.8% |
Q1 2021 | $2,229,000 | -2.8% | 428,571 | 0.0% | 0.19% | -44.5% |
Q4 2020 | $2,293,000 | +10.1% | 428,571 | 0.0% | 0.35% | +4.2% |
Q3 2020 | $2,083,000 | 0.0% | 428,571 | 0.0% | 0.33% | -45.2% |
Q2 2020 | $2,083,000 | +108.3% | 428,571 | 0.0% | 0.61% | +237.0% |
Q1 2020 | $1,000,000 | -50.0% | 428,571 | 0.0% | 0.18% | +12.4% |
Q4 2019 | $2,000,000 | – | 428,571 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bratton Capital Management, L.P. | 11,503,294 | $55,848,000 | 77.67% |
Bracebridge Capital, LLC | 428,571 | $2,083,000 | 0.33% |
Oak Grove Capital LLC | 89,000 | $432,000 | 0.20% |
Perceptive Advisors | 1,750,000 | $8,496,000 | 0.12% |
Virtu Financial LLC | 117,206 | $569,000 | 0.10% |
WEDBUSH SECURITIES INC | 103,240 | $501,000 | 0.05% |
J. Goldman & Co LP | 117,600 | $571,000 | 0.04% |
Engineers Gate Manager LP | 68,300 | $332,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 118,900 | $577,000 | 0.01% |
Brandywine Global Investment Management, LLC | 137,029 | $666,000 | 0.01% |